RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4578
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1224400; Gene model (P.falciparum): PF3D7_0806300; Gene product: ferlin, putative (ferlin-like protein, FLP)
Name tag: HA
Transgene
Transgene not Plasmodium: RFP
Promoter: Gene model: PBANKA_1319500; Gene model (P.falciparum): PF3D7_1455800; Gene product: LCCL domain-containing protein (LAP4; LCCL/lectin adhesive-like protein 4; CCp2)
3'UTR: Gene model: PBANKA_1359600; Gene product: transmission blocking target antigen precursor 6-cysteine protein (P48/45)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: PBANKA_0416100; Gene model (P.falciparum): PF3D7_0905300; Gene product: dynein heavy chain, putative
3'UTR: Gene model: PBANKA_1010600; Gene product: calmodulin, putative (cam)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Asexual bloodstage; Gametocyte/Gamete;
Last modified: 2 January 2019, 17:26
  *RMgm-4578
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 30597708
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 820cl1m1cl1 (RMgm-164)
Other information parent lineP. berghei ANKA 820cl1m1cl1 (RMgm-164) is a reference ANKA mutant line which expresses GFP under control of a male and RFP under control of a female gametocyte specific promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 19438517).
The mutant parasite was generated by
Name PI/ResearcherObrova K, Mair GR, Mueller AK
Name Group/DepartmentCenter for Infectious Diseases, Parasitology Unit
Name InstituteHeidelberg University Hospital
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-4578
Principal nameFLP::HA (820)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageThe FLP::HA fusion protein was detected in both schizont- and gametocyte-enriched blood stage lysates revealing the fusion protein at the expected size of 186 kDa. Antibody staining of fixed parasites confirmed expression in schizonts, showing a speckled signal. High abundance of FLP::HA was observed in gametocytes, localizing to widespread, distinct intracellular speckles. Immuno-gold typically localized close to the vesicle membranes, which is in agreement with FLP being a predicted transmembrane protein.
Gametocyte/GameteThe FLP::HA fusion protein was detected in both schizont- and gametocyte-enriched blood stage lysates revealing the fusion protein at the expected size of 186 kDa. Antibody staining of fixed parasites confirmed expression in schizonts, showing a speckled signal. High abundance of FLP::HA was observed in gametocytes, localizing to widespread, distinct intracellular speckles. Immuno-gold typically localized close to the vesicle membranes, which is in agreement with FLP being a predicted transmembrane protein.
Both male and female gametocytes showed a similar abundance and localization of FLP::HA. FLP-HA relocalizes to the cell peripery during activation of gametocytes.
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal HA-tagged version of FLP and expresses GFP under control of a male and RFP under control of a female gametocyte specific promoter. This mutant does not contain a drug-selectable marker. The hdhfr/yfcu selectable marker has been removed from the genome by negative selection

Protein (function)
The P. berghei ferlin-like protein (FLP, PBANKA_1224400) contains six predicted C2 domains, a C-terminal transmembrane domain and a Fer domain (a ferlin-specific motif of unknown function). These typical features cluster FLP together with ferlin (PBANKA_1319300) into the ferlin protein family.Ferlins are typically embedded in vesicular membranes via a single, C-terminal transmembrane domain with the N-terminus of the protein facing the cytosol.' Negative attempts to disrupt FLP (RMgm-4576) indicates an essential role during growth/multiplication of asexual stages.
Ferlins are established mediators of calcium-induced membrane fusion and regulated exocytosis in higher eukaryotes

Phenotype
FLP is essential for blood stage development/multiplication (see RMgm-4576) for unsuccessful attempts to disrupt the flp gene). In the 'promoter-swap' mutant RMgm-4577 the promoter of flp is replaced by an 'asexual blood stage’ promoter that is silent (or has a strongly reduced activity) in gametocytes (the promoter of clag, PBANKA_1400600). Analyses of this mutant provide evidence that FLP plays a role in egress of male and female gametocytes from the host red blood cell after activation.

Analyses of the mutant FLP::HA, expressing HA-tagged FLP shows that:
The  FLP::HA  fusion  protein was detected in both schizont- and gametocyte-enriched blood stage lysates revealing the fusion protein at the expected size of 186 kDa. Antibody staining of fixed parasites confirmed expression in schizonts, showing a speckled signal. High abundance of  FLP::HA was observed in gametocytes, localizing to widespread, distinct intracellular speckles. Immuno-gold typically localized close to the vesicle membranes, which is in agreement  with  FLP being a predicted transmembrane protein.
Both male and female gametocytes showed a similar abundance and localization of FLP::HA. FLP-HA relocalizes to the cell peripery during activation of gametocytes.


Additional information
From the paper:
'To  assess  whether  FLP  co-localizes  with  these  previously  published  egress  factors G377 (PBANKA_1463000) and PPLP2 (PBANKA_1432400),  we  generated flp::HA;g377::mCherry  and  flp::HA;pplp2::mCherry  double  mutants,  in  which FLP is endogenously tagged with HA while G377 and PPLP2 are endogenously tagged with mCherry, respectively. Neither of the lines showed co-localization between FLP and either of the two proteins, arguing against FLP localization to the G377-positive OBs (osmiophilic bodies) or to the PPLP2-positive egress vesicles.' 
 
Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1224400
Gene Model P. falciparum ortholog PF3D7_0806300
Gene productferlin, putative
Gene product: Alternative nameferlin-like protein, FLP
Details of the genetic modification
Name of the tagHA
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedYes
Name of PlasmoGEM construct/vector-
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasiteNo selectable marker
Promoter of the selectable markerNo
Selection (positive) procedureNo
Selection (negative) procedureNo
Additional remarks genetic modificationIn order to define the expression profile and localization of FLP during the parasite life cycle, we endogenously fused a hemagglutinin (HA) tag to the C-terminus of FLP using a PlasmoGEM vector.


The hdhfr/yfcu selectable marker cassette used to HA-tag FLP has been removed by negative selection
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameRFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasiteNo selectable marker
Promoter of the selectable markerNo
Selection (positive) procedureNo
Selection (negative) procedureNo
Additional remarks genetic modificationThe hdhfr/yfcu selectable marker cassette used to introduce RFP has been removed by negative selection
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1319500
Gene Model P. falciparum ortholog PF3D7_1455800
Gene productLCCL domain-containing protein
Gene product: Alternative nameLAP4; LCCL/lectin adhesive-like protein 4; CCp2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1359600
Gene producttransmission blocking target antigen precursor 6-cysteine protein
Gene product: Alternative nameP48/45
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasiteNo selectable marker
Promoter of the selectable markerNo
Selection (positive) procedureNo
Selection (negative) procedureNo
Additional remarks genetic modificationThe hdhfr/yfcu selectable marker cassette used to introduce GFP has been removed by negative selection
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0416100
Gene Model P. falciparum ortholog PF3D7_0905300
Gene productdynein heavy chain, putative
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1010600
Gene productcalmodulin, putative
Gene product: Alternative namecam
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4